← Insider Trading (US)

Najat Khan

Officer at RXRX
Data refreshed: Oct 11, 2026, 11:42 PM UTC
Total filings
2
Buys
0
$0
Sells
1
$79K
Grants & other
0
$0

Recent filings

RXRXSELL
Recursion Pharmaceuticals, Inc.
Sep 10, 202622,408 sh · $79K
RXRXOTHER
Recursion Pharmaceuticals, Inc.
Aug 18, 202680,498 sh · $254K